Inovio Pharma buy Piper Sandler
Start price
14.11.25
/
50%
€0.53
Target price
14.11.26
-
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 14.11.26. The prediction end date can be changed by Piper_Sandler at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Inovio Pharma | - | - |
| iShares Core DAX® | 0.795% | 1.458% |
| iShares Nasdaq 100 | -3.088% | -0.762% |
| iShares Nikkei 225® | -0.952% | -2.268% |
| iShares S&P 500 | -1.393% | 0.199% |
Comments by Piper_Sandler for this prediction
In the thread Inovio Pharma diskutieren
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Ratings data for INO provided by MarketBeat